Patricia Bath(1942 — 2019)
Patricia Bath
États-Unis
9 min read
An American ophthalmologist and inventor, Patricia Bath revolutionized cataract treatment by developing the Laserphaco Probe, a laser device patented in 1988. The first African American woman to receive a medical patent in the United States, she also co-founded the American Institute for the Prevention of Blindness.
Frequently asked questions
Key Facts
- 1942: Born in Harlem, New York
- 1968: Medical degree from Howard University College of Medicine
- 1974: First African American woman to lead an ophthalmology department in the United States (UCLA/Drew)
- 1988: Patent granted for the Laserphaco Probe — first African American woman to receive a medical patent
- 1993: Co-founder of the American Institute for the Prevention of Blindness
Works & Achievements
A revolutionary medical device combining a pulsed laser with an irrigation-aspiration system to remove cataracts with unmatched precision and speed. The first medical patent awarded to an African-American woman in the United States, it still serves as the foundation for modern cataract surgery techniques.
An innovative public eye health approach proposed by Bath, aimed at bringing care to underserved populations rather than waiting for them to seek it out. This model has had a lasting influence on community health policies in the United States.
A nonprofit organization dedicated to preventing blindness in marginalized populations, co-founded by Bath. She championed universal access to eye care and the training of physicians in developing countries.
A body of scientific publications documenting the disproportionate rates of blindness among African Americans and proposing structural solutions. This pioneering work laid the groundwork for the field of public health ophthalmology in the United States.
An initiative led by Bath in the later years of her career to harness digital technologies and telemedicine to deliver eye diagnoses and care to populations in Africa and Asia lacking access to specialists.
Anecdotes
At sixteen years old, Patricia Bath takes part in a cancer research program organized by Yeshiva University in New York. Her results are so impressive that they are presented at an international conference, and the program director declares she is the most promising researcher he has ever encountered.
While observing patients at Harlem Hospital in the 1970s, Patricia Bath notices that Black people suffer from blindness twice as often as white people, due to lack of access to ophthalmological care. This discovery leads her to create the concept of “community ophthalmology,” bringing care to underserved populations rather than waiting for them to come to the hospital.
To develop her laser device, Patricia Bath has to work in European laboratories: she conducts her research successively at the Laser Medical Center in Berlin, the Rothschild Eye Institute in Paris, and the University of Loughborough in England, since the necessary equipment does not yet exist in the United States. It is this international collaboration that allows her to finalize the invention.
After obtaining her patent in 1988, Patricia Bath uses her Laserphaco Probe to restore sight to patients who had been suffering from cataracts for more than thirty years. One of these patients, who had not seen for three decades, can once again recognize the faces of loved ones thanks to her invention — something no traditional surgical technique had ever managed to achieve.
Patricia Bath faces double discrimination throughout her career: as a woman and as a Black person. When she becomes in 1974 the first woman to join the faculty of the ophthalmology department at UCLA, she is denied access to certain laboratories. Rather than giving up, she conducts her research at Harlem Hospital and continues to publish work that ultimately earns international recognition.
Primary Sources
A method and apparatus for ablating and removing cataract lenses using a pulsed laser beam is disclosed. The apparatus includes a probe having an irrigation-aspiration system coupled with a laser source for delivering pulsed laser energy to ablate the lens.
The Laserphaco Probe combines laser energy delivery with simultaneous irrigation and aspiration, allowing the rapid ablation of cataract lenses with minimal trauma to surrounding ocular structures.
Blindness among Black Americans is at least twice that among white Americans. A community-based ophthalmology program can reduce this disparity by bringing preventive and therapeutic care directly to underserved populations.
The American Institute for the Prevention of Blindness is established to protect, preserve and restore the gift of sight, with a particular focus on populations historically deprived of adequate ophthalmic care.
Key Places
The neighborhood where Patricia Bath was born in 1942 and where she held her first consultations at Harlem Hospital. It was by observing patients in this underprivileged community that she became acutely aware of the racial inequalities in access to ophthalmic care.
A historically Black college and university (HBCU) where Patricia Bath earned her medical degree in 1968. Founded after the Civil War to train African Americans for the professions, this institution shaped her deep convictions about equality in access to healthcare.
A prestigious ophthalmology institute where Patricia Bath joined the faculty in 1974 as the first woman in the Department of Ophthalmology. She conducted much of her clinical and academic career there.
The laboratory where Patricia Bath carried out part of her research in the 1980s to develop the Laserphaco Probe, after finding that sufficiently advanced laser equipment was not available in the United States.
A Parisian institution specializing in ophthalmology where Bath continued her experiments with medical lasers, drawing on the expertise and cutting-edge equipment available across Europe.
